Francois Nader Alexion Pharmaceuticals, Inc. (ALXN) insider trading activity

ALXN Quotes by TradingView

Francois Nader is Director of ALEXION PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of ALXN, which is worth approximately $0. The most recent transaction as insider was on Jul 21, 2021, when has been sold 13,921 shares (Common Stock, par value $.0001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Francois Nader Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 21 2021
SELL
Sale (or disposition) back to the issuer
-
13,921 Reduced 100.0%
0 Common Stock, par valu...
May 20 2021
BUY
Grant, award, or other acquisition
-
2,635 Added 15.92%
13,921 Common Stock, par valu...

Also insider at

MRNA
Moderna, Inc. Healthcare
Director
PRVL
Prevail Therapeutics Inc.
Director
XLRN
ACCELERON PHARMA INC Healthcare
Director
TALS
Talaris Therapeutics, Inc. Healthcare
Director
FN

Francois Nader

Director
Cambridge, MA

Track Institutional and Insider Activities on ALXN

Follow ALEXION PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALXN shares.

Notify only if

Insider Trading

Get notified when an Alexion Pharmaceuticals, Inc. insider buys or sells ALXN shares.

Notify only if

News

Receive news related to ALEXION PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ALXN